Volume 21 Issue 4
Apr.  2023
Turn off MathJax
Article Contents
ZHAO Xinyue, MA Hualin, SUN Liping, ZHANG Xinzhou, . Tubulointerstitial nephritis and uveitis syndrome: a review[J]. Chinese Journal of General Practice, 2023, 21(4): 659-662. doi: 10.16766/j.cnki.issn.1674-4152.002954
Citation: ZHAO Xinyue, MA Hualin, SUN Liping, ZHANG Xinzhou, . Tubulointerstitial nephritis and uveitis syndrome: a review[J]. Chinese Journal of General Practice, 2023, 21(4): 659-662. doi: 10.16766/j.cnki.issn.1674-4152.002954

Tubulointerstitial nephritis and uveitis syndrome: a review

doi: 10.16766/j.cnki.issn.1674-4152.002954
Funds:

 81800489

 A2019416

 ZDSYS201504301616234

 粤卫函[2019]820号

  • Received Date: 2022-10-08
    Available Online: 2023-05-31
  • Tubulointerstitial nephritis and uveitis (TINU) syndrome is defined as the occurrence of tubulointerstitial nephritis (TIN) and uveitis. According to present epidemical statistics, women are more likely to be affected, especially in children and adolescents. The sequence of the clinical manifestations on oculus and kidney may be successive or simultaneous. Humoral immunity and cellular immunity play an important role in this immunological disorder with the reference of HLA gene family. Environmental triggers are also the possible causes of this syndrome. At the beginning of this syndrome, clinical manifestation would be dramatically insidious, with fever, rash, arthralgia, abdominal pain and weight loss. The typical renal manifestation is unexplained renal insufficiency caused by immune-mediated infiltration of renal tubulointerstitial inflammatory cells. The Ocular manifestation is specialized as bilateral acute anterior uveitis. It is an exclusive diagnosis in this syndrome. The infectious uveitis and other systemic and autoimmune diseases caused by bilateral uveitis should be excluded. High heterogeneity has been described in the sequence of uveitis and interstitial nephritis. The challenges in diagnosing this syndrome lie in the long-time interval between the oculus and the kidney and it ' s hard to figure out which organ is affected when systematic therapeutic methods have been used in the one. Furthermore, there is no laboratory examination that can differentiate this syndrome. The process and criticism of diagnosing this syndrome has been in debated yet. According to present reports, partial and systematic steroid therapy has been shown to be effective. From a prognostic point of view, acute tubulointerstitial nephritis a self-limited disease, and the risk of developing chronic kidney disease in the adult population should be taken into account. In contrast, uveitis, especially in children, can persist or recur.

     

  • loading
  • [1]
    AMARO D, CARREÑO E, STEEPLES L R, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a review[J]. Br J Ophthalmol, 2020, 104(6): 742-747. doi: 10.1136/bjophthalmol-2019-314926
    [2]
    ABRAHAM G, AGARWAL S K, GOWRISHANKAR S, et al. Chronic kidney disease of unknown etiology: hotspots in India and other Asian countries[J]. Semin Nephrol, 2019, 39(3): 272-277. doi: 10.1016/j.semnephrol.2019.02.005
    [3]
    REGUSCI A, LAVA S A G, MILANI G P, et al. Tubulointerstitial nephritis and uveitis syndrome: a systematic review[J]. Nephrol Dial Transplant, 2022, 37(5): 876-886. doi: 10.1093/ndt/gfab030
    [4]
    CARVALHO T J, CALÇA R, CASSIS J, et al. Tubulointerstitial nephritis and uveitis syndrome in a female adult[J]. BMJ Case Rep, 2019, 12(1): e227688. DOI: 10.1136/bcr-2018-227688.
    [5]
    OKAFOR L O, HEWINS P, MURRAY P I, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors[J]. Orphanet J Rare Dis, 2017, 12(1): 128. doi: 10.1186/s13023-017-0677-2
    [6]
    KANNO H, ISHIDA K, YAMADA W, et al. Clinical and genetic features of tubulointerstitial nephritis and uveitis syndrome with long-term follow-up[J]. J Ophthalmol, 2018, 2018: 4586532. DOI: 10.1155/2018/4586532.
    [7]
    MACKENSEN F, DAVID F, SCHWENGER V, et al. HLA-DRB1*0102 is associated with TINU syndrome and bilateral, sudden-onset anterior uveitis but not with interstitial nephritis alone[J]. Br J Ophthalmol, 2011, 95(7): 971-975. doi: 10.1136/bjo.2010.187955
    [8]
    REDDY A K, HWANG Y S, MANDELCORN E D, et al. HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis[J]. Am J Ophthalmol, 2014, 157(3): 678-86. e1-2. doi: 10.1016/j.ajo.2013.12.006
    [9]
    LOPES B O, BRÍZIDO M S, COSTA A C, et al. Tubulointerstitial nephritis and uveitis syndrome: case series and literature review[J]. Case Rep Ophthalmol Med, 2021, 2021: 1812271. DOI: 10.1155/2021/1812271.
    [10]
    CARAVACA-FONTÁN F, SHABAKA A, SÁNCHEZ-ÁLAMO B, et al. Recurrent acute interstitial nephritis: what lies beneath[J]. Clin Kidney J, 2021, 14(1): 197-204. doi: 10.1093/ckj/sfaa018
    [11]
    KOLOMEYER A M, KODATI S. Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome[J]. Eur J Ophthalmol, 2015, 26(1): e14-6. http://www.onacademic.com/detail/journal_1000040379400110_a3e9.html
    [12]
    SANTORO D, VITA G, ROVITO S, et al. Drug-induced TINU syndrome and genetic characterization[J]. Clin Nephrol, 2012, 78(3): 230-236.
    [13]
    KAWAMATA M, AKIMOTO T, SUGASE T, et al. Tubulointerstitial nephritis and uveitis syndrome: Are drugs offenders or bystanders?[J]. Clin Med Insights Case Rep, 2016, 9: 21-24. http://europepmc.org/articles/PMC4795485/
    [14]
    REDMON J H, LEVINE K E, LEBOV J, et al. A comparative review: Chronic Kidney Disease of unknown etiology (CKDu) research conducted in Latin America versus Asia[J]. Environ Res, 2021, 192: 110270. DOI: 10.1016/j.envres.2020.110270.
    [15]
    齐彩云, 许二赫. 托吡酯与其诱导的葡萄膜炎回顾总结[J]. 中国医药, 2020, 15(2): 314-316. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202002039.htm

    QI C Y, XU E H. Review of topiramate and uveitis induced by topiramate[J]. China Medicine, 2020, 15(2): 314-316. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG202002039.htm
    [16]
    KWIATKOWSKA E, DOMAÑSKI L, DZIEDZIEJKO V, et al. The mechanism of drug nephrotoxicity and the methods for preventing kidney damage[J]. Int J Mol Sci, 2021, 22(11): 6109. DOI: 10.3390/ijms22116109.
    [17]
    CLIVE D M, VANGURI V K. The syndrome of tubulointerstitial nephritis with uveitis (TINU) [J]. Am J Kidney Dis, 2018, 72(1): 118-128. doi: 10.1053/j.ajkd.2017.11.013
    [18]
    Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for tubulointerstitial nephritis with uveitis syndrome[J]. Am J Ophthalmol, 2021, 228: 255-261. doi: 10.1016/j.ajo.2021.03.041
    [19]
    TAN Y, YU F, QU Z, et al. Modified C-reactive protein might be a target autoantigen of TINU syndrome[J]. Clin J Am Soc Nephrol, 2011, 6(1): 93-100. doi: 10.2215/CJN.09051209
    [20]
    LI C, SU T, CHU R, et al. Tubulointerstitial nephritis with uveitis in Chinese adults[J]. Clin J Am Soc Nephrol, 2014, 9(1): 21-28. doi: 10.2215/CJN.02540313
    [21]
    HAYASHI A, TAKAHASHI T, UEDA Y, et al. Long-term clinical characteristics and renal prognosis of children with tubulointerstitial nephritis and uveitis syndrome[J]. Pediatr Nephrol, 2021, 36(8): 2319-2325. doi: 10.1007/s00467-021-04956-6
    [22]
    HEANEY A, MCLOONE E, WILLIAMS M, et al. Tubulointerstitial nephritis and uveitis in Northern Ireland[J]. Eye (Lond), 2022, 36(8): 1645-1650. doi: 10.1038/s41433-021-01677-w
    [23]
    KOREISHI A F, ZHOU M, GOLDSTEIN D A. Tubulointerstitial nephritis and uveitis syndrome: characterization of clinical features[J]. Ocul Immunol Inflamm, 2021, 29(7-8): 1312-1317. doi: 10.1080/09273948.2020.1736311
    [24]
    曹赛霞, 李玉慧, 杨书彦, 等. 白塞综合征眼部损害患者的临床及实验室特点分析[J]. 中华全科医学, 2020, 18(5): 717-719, 738. doi: 10.16766/j.cnki.issn.1674-4152.001337

    CAO S X, LI Y H, YANG S Y, et al. Analysis of clinical and laboratory characteristics of ocular damage in patients with Behcet's syndrome[J]. Chinese Journal of General Practice, 2020, 18(5): 717-719, 738. doi: 10.16766/j.cnki.issn.1674-4152.001337
    [25]
    谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8

    XIE C H, LI Z J. Diagnosis and treatment of systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
    [26]
    陈欣, 刘红, 金是, 等. IgG4相关性肾病2例报告[J]. 中国临床医学, 2021, 28(6): 1092-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202106034.htm

    CHEN X, LIU H, JIN S, et al. gG4-related kidney disease: 2 cases report[J]. Chinese Journal Of Clinical Medicine, 2021, 28(6): 1092-1097. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202106034.htm
    [27]
    OLIVA-DAMASO N, OLIVA-DAMASO E, PAYAN J. Acute and chronic tubulointerstitial nephritis of rheumatic causes[J]. Rheum Dis Clin North Am, 2018, 44(4): 619-633. http://www.onacademic.com/detail/journal_1000040434251110_c682.html
    [28]
    [29]
    CHEVALIER A, DUFLOS C, CLAVE S, et al. Renal prognosis in children with tubulointerstitial nephritis and uveitis syndrome[J]. Kidney Int Rep, 2021, 6(12): 3045-3053.
    [30]
    PEPPLE K L, LAM D L, FINN L S, et al. Urinary beta2-microglobulin testing in pediatric uveitis: a case report of a 9-year-old boy with renal and ocular sarcoidosis[J]. Case Rep Ophthalmol, 2015, 6(1): 101-105. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395824/pdf/cop-0006-0101.pdf
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (269) PDF downloads(15) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return